Parkinson's Disease Trial, Recruiting NCT06476912 Sponsor: National Taiwan University Hospital Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06476912
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with idiopathic Parkinson's disease (a form of Parkinson's disease with no known external cause)
  • People who score below 13 (non-anxiety group) or above 14 (anxiety group) on the Parkinson Anxiety Scale, a standardised questionnaire that measures anxiety levels
  • People who are able to walk 20 metres without any assistance
  • People who do not have any other neurological (brain or nervous system) conditions

Who may not be able to join:

  • People who score below 26 on the Mini-Mental State Examination, which is a standard test used to assess memory and thinking ability
  • People who have depression
  • People who have had brain surgery, such as deep brain stimulation (a procedure where a device is implanted in the brain)
  • People who have visual impairments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cheng-Ya Huang, PhD, National Taiwan University

Phone: 886-2-3366-8131

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 September 2023
Est. completion
31 July 2024

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

EEG relative power

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov